1. Home
  2. Stocks
  3. Suvenphar Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Suven Pharmaceuticals Share Price Suven Pharmaceuticals

    Mid Cap
    ₹644.55
    -5.85 (-0.9%)
    19 April, 2024 19:22 BSE: 543064 NSE: SUVENPHARISIN: INE03QK01018

    Start SIP in Suven Pharmaceuticals

    Start SIP

    Suven Pharmaceuticals Performance

    Day Range

    • Low 632
    • High 650
    ₹ 644

    52 Week Range

    • Low 465
    • High 768
    ₹ 644
    • Open Price639
    • Previous Close650
    • Volume70598

    Suven Pharmaceuticals Share Price

    • Over 1 Month +4.32%
    • Over 3 Month -5.32%
    • Over 6 Month +11.13%
    • Over 1 Year +38.6%

    Suven Pharmaceuticals Key Statistics

    P/E Ratio 44.2
    PEG Ratio -20.7
    Market Cap Cr 16,408
    Price to Book Ratio 9.5
    EPS 16.6
    Dividend 0
    Relative Strength Index 50.27
    Money Flow Index 58.36
    MACD Signal -5.01
    Average True Range 24.34
    Suven Pharmaceuticals Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 213225344364
    Operating Expenses Qtr Cr 145127174190
    Operating Profit Qtr Cr 6897170175
    Depreciation Qtr Cr 11101111
    Interest Qtr Cr 1112
    Tax Qtr Cr 17264342
    Net Profit Qtr Cr 5275124130
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,375
    Operating Expenses Annual Cr 747
    Operating Profit Annual in Cr 583
    Depreciation Cr 43
    Interest Annual Cr 5
    Tax Annual Cr 147
    Net Profit Annual Cr 433
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 484
    Cash from Investing Activity Annual Cr -236
    Cash from Financing Annual Activity Cr -236
    Net Cash Flow Annual Cr 13
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,749
    Fixed Assets Annual Cr 677
    Total Non Current Assets Annual Cr 1,003
    Total Current Assets Annual Cr 955
    Total Assets Annual Cr 1,958
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 69
    ROE Annual % 25
    ROCE Annual % 32
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 47
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 220231348369
    Operating Expenses Qtr Cr 155133181200
    Operating Profit Qtr Cr 6598167169
    Depreciation Qtr Cr 13121312
    Interest Qtr Cr 1112
    Tax Qtr Cr 19264342
    Net Profit Qtr Cr 4780121124
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,387
    Operating Expenses Annual Cr 774
    Operating Profit Annual in Cr 567
    Depreciation Cr 48
    Interest Annual Cr 5
    Tax Annual Cr 148
    Net Profit Annual Cr 411
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 451
    Cash from Investing Activity Annual Cr -195
    Cash from Financing Annual Activity Cr -236
    Net Cash Flow Annual Cr 20
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,735
    Fixed Assets Annual Cr 828
    Total Non Current Assets Annual Cr 955
    Total Current Assets Annual Cr 1,011
    Total Assets Annual Cr 1,966
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 68
    ROE Annual % 24
    ROCE Annual % 31
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 46
    Sign Up to Know More
    Invest in Suven Pharmaceuticals

    Suven Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹644.55
    -5.85 (-0.9%)
    pointer
    • Bullish Moving Average
    • ___
    • 13
    • Bearish Moving Average
    • ___
    • 3
    • 20 Day
    • ₹641.52
    • 50 Day
    • ₹649.23
    • 100 Day
    • ₹643.00
    • 200 Day
    • ₹610.24
    • 20 Day
    • ₹640.71
    • 50 Day
    • ₹648.81
    • 100 Day
    • ₹668.97
    • 200 Day
    • ₹600.33

    Suven Pharmaceuticals Resistance and Support

    PIVOT
    ₹642.24
    Resistance
    First Resistance 652.22
    Second Resistance 659.88
    Third Resistance 669.87
    RSI 50.27
    MFI 58.36
    MACD Single Line -5.01
    MACD -4.15
    Support
    First Resistance 634.57
    Second Resistance 624.58
    Third Resistance 616.92

    Suven Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 76,014 3,341,575 43.96
    Week 142,742 7,329,802 51.35
    1 Month 197,409 11,520,809 58.36
    6 Month 429,512 23,541,547 54.81

    Suven Pharmaceuticals Result Highlights

    Suven Pharmaceuticals Synopsis

    NSE-Medical-Generic Drugs

    Suven Pharmaceutical is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 1330.08 Cr. and Equity Capital is Rs. 25.46 Cr. for the Year ended 31/03/2023. Suven Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 06/11/2018 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24299TG2018PLC128171 and registration number is 128171.
    Market Cap 16,333
    Sales 1,146
    Shares in Float 10.18
    No of funds 166
    Yield 0.18
    Book Value 9.46
    U/D Vol ratio 3.8
    LTDebt / Equity 2
    Alpha 0.07
    Beta 0.59

    Suven Pharmaceuticals

    Owner NameMar-24Dec-23Sep-23Jun-23
    Promoters 50.1%60%60%60%
    Mutual Funds 15.26%13.4%12.15%9.12%
    Insurance Companies 1.57%1.89%1.38%0.11%
    Foreign Portfolio Investors 9.54%10.14%10.01%9.5%
    Financial Institutions/ Banks
    Individual Investors 10.51%10.87%11.76%12.8%
    Others 13.02%3.7%4.7%8.47%

    Suven Pharmaceuticals Management

    Name Designation
    Mr. Annaswamy Vaidheesh Executive Chairman
    Mr. V Prasada Raju Managing Director
    Mr. Pankaj Patwari Non Exe.Non Ind.Director
    Ms. Shweta Jalan Non Exe.Non Ind.Director
    Ms. Matangi Gowrishankar Independent Director
    Mr. Vinod Rao Independent Director
    Mr. K G Ananthakrishnan Independent Director
    Mr. Pravin Rao Udhyavara Bhadya# Independent Director

    Suven Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Suven Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-02-05 Quarterly Results
    2023-11-09 Quarterly Results
    2023-08-08 Quarterly Results
    2023-05-25 Audited Results
    2023-02-06 Quarterly Results
    Date Purpose Remarks
    2022-09-12 INTERIM Rs.1.00 per share(100%)Interim Dividend
    2022-09-12 SPECIAL Rs.5.00 per share(500%)Special Dividend
    2022-05-17 INTERIM Re.1.00 per shaer (100%) Second Interim Dividend
    2022-05-17 SPECIAL Rs.1.00 per share(100%)Special Dividend
    2022-02-16 INTERIM Rs.1.00 per share(100%)Interim Dividend

    Suven Pharmaceuticals MF Shareholding

    Name Amount(cr)
    UTI Flexi Cap Fund Regular Plan Growth 24,504
    Axis Small Cap Fund Regular Growth 19,030
    DSP ELSS Tax Saver Fund Regular Plan Growth 14,076
    HSBC Small Cap Fund Fund Regular Growth 13,401
    DSP Equity Opportunities Fund Growth 10,812

    Suven Pharmaceuticals FAQs

    What is Share Price of Suven Pharmaceuticals ?

    Suven Pharmaceuticals share price is ₹644 As on 19 April, 2024 | 19:08

    What is the Market Cap of Suven Pharmaceuticals ?

    The Market Cap of Suven Pharmaceuticals is ₹16408 Cr As on 19 April, 2024 | 19:08

    What is the P/E ratio of Suven Pharmaceuticals ?

    The P/E ratio of Suven Pharmaceuticals is 44.2 As on 19 April, 2024 | 19:08

    What is the PB ratio of Suven Pharmaceuticals ?

    The PB ratio of Suven Pharmaceuticals is 9.5 As on 19 April, 2024 | 19:08

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.